Total Payments
$3,648
2024 Payments
$527.31
Companies
25
Transactions
156
Medicare Patients
12,245
Medicare Billing
$868,832
Payment Breakdown by Category
Food & Beverage$3,641 (99.8%)
Education$6.97 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,641 | 155 | 99.8% |
| Education | $6.97 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $850.75 | 45 | $0 (2024) |
| Boston Scientific Corporation | $650.29 | 19 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $390.56 | 14 | $0 (2024) |
| PFIZER INC. | $260.48 | 20 | $0 (2024) |
| Medtronic, Inc. | $224.17 | 2 | $0 (2022) |
| Amarin Pharma Inc. | $212.93 | 10 | $0 (2021) |
| Merck Sharp & Dohme LLC | $157.73 | 10 | $0 (2023) |
| HeartFlow, Inc. | $130.39 | 1 | $0 (2021) |
| CVRx, Inc. | $129.97 | 1 | $0 (2023) |
| Esperion Therapeutics, Inc. | $94.33 | 6 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $527.31 | 28 | Novartis Pharmaceuticals Corporation ($209.86) |
| 2023 | $746.72 | 37 | Boston Scientific Corporation ($197.26) |
| 2022 | $530.40 | 21 | Medtronic, Inc. ($224.17) |
| 2021 | $841.84 | 41 | Novartis Pharmaceuticals Corporation ($187.24) |
| 2020 | $57.99 | 4 | Novartis Pharmaceuticals Corporation ($26.61) |
| 2019 | $354.56 | 4 | Boston Scientific Corporation ($290.42) |
| 2018 | $218.69 | 6 | Novartis Pharmaceuticals Corporation ($121.52) |
| 2017 | $370.05 | 15 | Janssen Pharmaceuticals, Inc ($136.10) |
All Payment Transactions
156 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $27.81 | General |
| Category: Cardiovascular | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/02/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $25.98 | General |
| 09/23/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/21/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Cardiology | ||||||
| 08/14/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/31/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/24/2024 | AGEPHA Pharma FZ LLC | LODOCO (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Cardiovascular Diseases | ||||||
| 07/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.36 | General |
| Category: DIABETES | ||||||
| 06/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/29/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/11/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Not Applicable | ||||||
| 04/10/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.39 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/01/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $23.23 | General |
| 03/26/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/25/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/20/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Not Applicable | ||||||
| 03/19/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/13/2024 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/08/2024 | Boston Scientific Corporation | BodyGuardian (Device) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: CDS - Holter Monitoring_RM | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 3,666 | 5,412 | $840,732 | $263,039 |
| 2022 | 29 | 2,958 | 3,929 | $638,916 | $205,850 |
| 2021 | 25 | 2,780 | 3,824 | $645,145 | $221,825 |
| 2020 | 33 | 2,841 | 3,726 | $591,242 | $178,117 |
Total Patients
12,245
Total Services
16,891
Medicare Billing
$868,832
Procedure Codes
127
All Medicare Procedures & Services
127 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 675 | 1,325 | $341,850 | $118,567 | 34.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 364 | 391 | $72,996 | $20,431 | 28.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 131 | 153 | $53,091 | $19,913 | 37.5% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 127 | 472 | $76,936 | $17,903 | 23.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 86 | 180 | $31,680 | $10,896 | 34.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 96 | 96 | $38,400 | $10,698 | 27.9% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 132 | 269 | $35,239 | $10,093 | 28.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 64 | 76 | $19,152 | $6,881 | 35.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 558 | 663 | $33,150 | $6,375 | 19.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 86 | 87 | $17,139 | $5,031 | 29.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 518 | 669 | $15,387 | $4,248 | 27.6% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 40 | 118 | $12,626 | $3,594 | 28.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 16 | 17 | $9,860 | $3,353 | 34.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $8,964 | $2,684 | 29.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 14 | 14 | $5,768 | $2,222 | 38.5% |
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Facility | 2023 | 32 | 32 | $7,712 | $2,204 | 28.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 30 | $5,220 | $2,106 | 40.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2023 | 74 | 74 | $6,790 | $2,085 | 30.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 13 | $6,396 | $1,625 | 25.4% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 102 | 105 | $5,250 | $1,529 | 29.1% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 130 | 131 | $5,109 | $1,406 | 27.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 14 | $4,690 | $1,375 | 29.3% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Facility | 2023 | 24 | 24 | $4,608 | $1,284 | 27.9% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 113 | 115 | $3,680 | $1,023 | 27.8% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 12 | 12 | $3,336 | $973.18 | 29.2% |
About Dr. Richard Baum, MD
Dr. Richard Baum, MD is a Cardiovascular Disease healthcare provider based in San Antonio, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1013994987.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Baum, MD has received a total of $3,648 in payments from pharmaceutical and medical device companies, with $527.31 received in 2024. These payments were reported across 156 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($3,641).
As a Medicare-enrolled provider, Baum has provided services to 12,245 Medicare beneficiaries, totaling 16,891 services with total Medicare billing of $868,832. Data is available for 4 years (2020–2023), covering 127 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location San Antonio, TX
- Active Since 12/30/2005
- Last Updated 07/21/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1013994987
Products in Payments
- ENTRESTO (Drug) $653.93
- XARELTO (Drug) $390.56
- WATCHMAN (Device) $333.86
- ELIQUIS (Drug) $276.99
- Vascepa (Drug) $212.93
- LEQVIO (Drug) $196.82
- VERQUVO (Drug) $157.73
- FFRct (Device) $130.39
- Barostim Neo System (Device) $129.97
- SELECTSECURE (Device) $121.05
- COREVALVE EVOLUT R (Device) $103.12
- NEXLETOL (Drug) $94.33
- LifeVest (Device) $87.17
- BodyGuardian (Device) $77.92
- MULTAQ (Drug) $65.86
- Repatha (Biological) $58.94
- Arcalyst (Drug) $50.60
- ATRICLIP LAA EXCLUSION SYSTEM (Device) $48.97
- WATCHMAN Access System (Device) $34.31
- JARDIANCE (Drug) $28.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in San Antonio
Robert Chilton, Do, DO
Cardiovascular Disease — Payments: $1.8M
Cardiovascular Disease $1.8M
Dr. Chandrasekhar Kunavarapu, M.d, M.D
Cardiovascular Disease — Payments: $456,612
Cardiovascular Disease $456,612
Eric Stocker, Md, MD
Cardiovascular Disease — Payments: $376,204
Cardiovascular Disease $376,204
Mark Colligan, Md, MD
Cardiovascular Disease — Payments: $198,267
Cardiovascular Disease $198,267
Wassim Choucair, M.d, M.D
Cardiovascular Disease — Payments: $135,616
Cardiovascular Disease $135,616
Dr. Jamil Malik, Md, MD
Cardiovascular Disease — Payments: $105,345
Cardiovascular Disease $105,345